Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design

• Main Authors: Luda Feng (Author), Fang Han (Author), Li Zhou (Author), Shengxian Wu (Author), Yawei Du (Author), Dandan Zhang (Author), Chi Zhang (Author), Ying Gao (Author)
• 格式: 圖書
• 出版: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Background: Although revascularization treatment is recommended as the first-line therapy for patients with non-minor acute ischemic stroke (AIS), it only benefits a minority of patients. Previous studies have reported the positive effects of Panax notoginseng saponins (PNS) (Xueshuantong lyophilize...